Chemistry:ADB-HEXINACA

From HandWiki

ADB-HEXINACA (also known as ADB-HINACA and ADMB-HEXINACA) is a cannabinoid designer drug that has been found as an ingredient in some synthetic cannabis products, first appearing in early 2021. It is a longer chain homologue of previously encountered synthetic cannabinoid compounds such as ADB-BUTINACA and ADB-PINACA.[1][2] The pharmacology of ADB-HEXINACA and numerous analogues at CB1 and CB2 receptors has been reported.[3]

See also

References

  1. ↑ "The metabolism of the synthetic cannabinoids ADB-BUTINACA and ADB-4en-PINACA and their detection in forensic toxicology casework and infused papers seized in prisons". Drug Testing and Analysis 14 (4): 634–652. November 2021. doi:10.1002/dta.3203. PMID 34811926. https://discovery.dundee.ac.uk/en/publications/a9c83a12-49d4-4b09-8f08-83bac57bcc24. 
  2. ↑ "Synthesis, characterisation, detection and quantification of a novel hexyl-substituted synthetic cannabinoid receptor agonist: (S)-N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-hexyl-1H-indazole-3-carboxamide (ADB-HINACA).". Forensic Chemistry 26. December 2021. doi:10.1016/j.forc.2021.100354. https://e-space.mmu.ac.uk/628354/3/Gilbert_ADBHINACA_R2.pdf. 
  3. ↑ "Synthesis and Functional Evaluation of Synthetic Cannabinoid Receptor Agonists Related to ADB-HEXINACA". ACS Chemical Neuroscience 15 (9): 1787–1812. April 2024. doi:10.1021/acschemneuro.3c00818. PMID 38597712. https://pubs.acs.org/doi/10.1021/acschemneuro.3c00818. 



Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:ADB-HEXINACA&oldid=4177534"